About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Hematology
›
top-articles
Department of Hematology
22
(top 2%)
papers
709
(top 2%)
citations
13
(top 2%)
h
-index
19
(top 2%)
g
-index
23
all documents
786
doc citations
326
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)
Annals of Oncology
2019
147
2
Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party
Blood
2011
140
3
Analysis of the Ten-Eleven Translocation 2 (TET2) gene in familial myeloproliferative neoplasms
Blood
2009
96
4
Waldenström’s macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology
2018
63
5
Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology
2013
62
6
Germline JAK2 Mutations In The Kinase Domain Are Responsible For Hereditary Thrombocytosis and Are Resistant To JAK2 and HSP90 Inhibitors
Blood
2013
46
7
Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications
Blood Cells, Molecules, and Diseases
2012
43
8
Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study
Blood Advances
2018
34
9
Deferasirox and Vitamin D Improves Overall Survival in Elderly Patients with Acute Myeloid Leukemia after Demethylating Agents Failure
PLoS ONE
2013
33
10
Autologous stem cell transplantation for adult acute leukemia
Current Opinion in Oncology
2002
30
11
Interest of the association azacitidine–lenalidomide as frontline therapy in high-risk myelodysplasia or acute myeloid leukemia with complex karyotype
Leukemia
2012
17
12
Single-Unit versus Double-Unit Umbilical Cord Blood Transplantation in Children and Young Adults with Residual Leukemic Disease
Biology of Blood and Marrow Transplantation
2019
17
13
The microenvironment in lymphomas – Dissecting the complex crosstalk between tumor cells and ‘by-stander’ cells
Seminars in Cancer Biology
2014
16
14
Invasive Aspergillosis of the Mediastinum and Left Hilum: CT Features
American Journal of Roentgenology
2004
13
15
Dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide (DPACE) is an effective salvage regimen for multiple myeloma refractory to novel agents
Leukemia and Lymphoma
2013
9
16
The Case ∣ The case presentation
Kidney International
2007
8
17
Rituximab as first‐line therapy for acquired haemophilia
A
: a single‐centre 10‐year experience
Haemophilia
2016
6
18
Is Azacitidine (AZA) Really Effective in High Risk MDS Patients with Chromosome 7 Abnormalities (Abn 7)? Results of a Retrospective Study From the GFM and GESMD Registries
Blood
2012
4
19
Management of relapsed or refractory follicular lymphoma patients in daily practice – a French non-interventional study
Leukemia and Lymphoma
2018
2
20
Study of V617F JAK2-Positive and JAK2-Negative Patients within 18 Families with Myeloproliferative Disorders (MPD): Disease Characteristics and Evolution, EPOR and MPL Analysis.
Blood
2006
0
21
Long-Term Follow-up of 94 Families with Myeloproliferative Neoplasms: Implications of the V617F JAK2 mutation, Life Expectancy and Complication Rates
Blood
2010
0
22
Hematopoietic Multipotent Progenitor Cells Mobilized by G-CSF Can Inhibit Gvhd
Blood
2011
0
23
Interest of the Association Azacitidine-Lenalidomide As Front Line Therapy in High-Risk Myelodysplasia (MDS) or Acute Myeloid Leukemia (AML) with Complex Karyotype
Blood
2011
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.